# Intermittent ART in Primary HIV Infection

> **NCT02300623** · PHASE4 · COMPLETED · sponsor: **Juan A. Arnaiz** · enrollment: 12 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Antiretroviral therapy plus Interleukin-2
- **DRUG:** Antiretroviral therapy alone

## Key facts

- **NCT ID:** NCT02300623
- **Lead sponsor:** Juan A. Arnaiz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02300623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02300623, "Intermittent ART in Primary HIV Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02300623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*